RL
BMY icon

Ruffer LLP’s Bristol-Myers Squibb BMY Stock Holding History

Ruffer LLP’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-151,760
Closed -$6.84M – 158
2025
Q3 		$6.84M Buy
+151,760
New +$7.09M 0.38% 42
2023
Q2 		– Sell
-4,504
Closed -$312K – 72
2023
Q1 		$312K Sell
4,504
-72,451
-94% -$5.11M 0.01% 85
2022
Q4 		$5.55M Sell
76,955
-262,276
-77% -$19.8M 0.37% 40
2022
Q3 		$23.8M Sell
339,231
-1,207,574
-78% -$87.6M 1.49% 23
2022
Q2 		$119M Sell
1,546,805
-1,761,973
-53% -$134M 4.69% 8
2022
Q1 		$242M Sell
3,308,778
-1,628,767
-33% -$109M 5.65% 6
2021
Q4 		$306M Buy
4,937,545
+988,450
+25% +$58M 7.38% 4
2021
Q3 		$234M Sell
3,949,095
-300,178
-7% -$19.8M 7.4% 3
2021
Q2 		$284M Buy
4,249,273
+52,417
+1% +$3.42M 7.95% 4
2021
Q1 		$265M Buy
4,196,856
+2,327,044
+124% +$145M 8.11% 4
2020
Q4 		$116M Buy
1,869,812
+1,617,638
+641% +$99.5M 3.93% 10
2020
Q3 		$15.2M Sell
252,174
-2,993
-1% -$180K 0.71% 26
2020
Q2 		$15.8M Sell
255,167
-475,735
-65% -$28.5M 0.61% 27
2020
Q1 		$40.7M Sell
730,902
-4,522,472
-86% -$276M 1.85% 16
2019
Q4 		$337M Buy
5,253,374
+5,135,274
+4,348% +$294M 9.83% 2
2019
Q3 		$5.99M Sell
118,100
-3,370
-3% -$158K 0.17% 39
2019
Q2 		$5.51M Buy
+121,470
New +$5.66M 0.13% 46

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ruffer LLP's BMY Position: Q4 2025 in Review

Ruffer LLP sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 151,760 shares — an estimated $6.84M sold.

Ruffer LLP first reported a position in BMY in Q2 2019 and held it in 17 quarters. The position peaked at $337M in Q4 2019. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Ruffer LLP reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Ruffer LLP sold 151,760 Bristol-Myers Squibb shares in Q4 2025, an estimated $6.84M.
  • Ruffer LLP first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 17 quarters.
  • Ruffer LLP's Bristol-Myers Squibb position peaked at $337M in Q4 2019.
  • 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Ruffer LLP's 13F filing for Q4 2025, filed 28 Jan 2026.